The assay used a stable PC12 cell line containing a gene fusion of Exon 1 of the Huntingtin gene linked to GFP under the control of the inducible ecdysone promoter to simulate Huntington's disease. The cells expressed 103 polyglutamines, causing cell death and GFP aggregates. The amount of cell death and the size and intensity of GFP aggregates were quantified, and small molecules that reduced aggregate formation were identified in a quantitative high throughput screen conducted on the cells. Is the molecule effective to this assay?